BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10653917)

  • 1. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
    Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
    Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
    Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
    Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
    Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
    Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
    Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
    Chien YJ; Chen WJ; Hsu WL; Chiou SS
    Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes.
    Hara K; Ikeda M; Saito S; Matsumoto S; Numata K; Kato N; Tanaka K; Sekihara H
    Hepatol Res; 2002 Nov; 24(3):228. PubMed ID: 12393024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of lactoferrin against canine herpesvirus.
    Tanaka T; Nakatani S; Xuan X; Kumura H; Igarashi I; Shimazaki Ki
    Antiviral Res; 2003 Nov; 60(3):193-9. PubMed ID: 14638395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides.
    Berkhout B; van Wamel JL; Beljaars L; Meijer DK; Visser S; Floris R
    Antiviral Res; 2002 Aug; 55(2):341-55. PubMed ID: 12103434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
    Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
    Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.
    Li S; Zhou H; Huang G; Liu N
    Med Microbiol Immunol; 2009 Feb; 198(1):19-25. PubMed ID: 18810491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Mayaro virus infection by bovine lactoferrin.
    Carvalho CA; Sousa IP; Silva JL; Oliveira AC; Gonçalves RB; Gomes AM
    Virology; 2014 Mar; 452-453():297-302. PubMed ID: 24606707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
    Ammendolia MG; Marchetti M; Superti F
    Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydrolysis and microwave treatment on the antibacterial activity of native bovine milk lactoferrin against Cronobacter sakazakii.
    Harouna S; Franco I; Carramiñana JJ; Blázquez A; Abad I; Pérez MD; Calvo M; Sánchez L
    Int J Food Microbiol; 2020 Apr; 319():108495. PubMed ID: 31911211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response trial of lactoferrin in patients with chronic hepatitis C.
    Okada S; Tanaka K; Sato T; Ueno H; Saito S; Okusaka T; Sato K; Yamamoto S; Kakizoe T
    Jpn J Cancer Res; 2002 Sep; 93(9):1063-9. PubMed ID: 12359061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
    Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
    BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
    Redwan el-RM; Tabll A
    J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus.
    Ikeda M; Sugiyama K; Mizutani T; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
    Virus Res; 1998 Aug; 56(2):157-67. PubMed ID: 9783464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of inhibition effect of bovine lactoferrin in vitro on hepatitis B surface antigen].
    Li S; Huang G; Zhou H; Liu N
    Wei Sheng Yan Jiu; 2008 Mar; 37(2):196-8. PubMed ID: 18589607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of iron saturation of bovine lactoferrin on the inhibition of hepatitis B virus
    Zhou H; Zhu Y; Liu N; Zhang W; Han J
    PeerJ; 2024; 12():e17302. PubMed ID: 38737747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-papillomavirus activity of human and bovine lactoferricin.
    Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
    Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.